Mengxuan Shu
Overview
Explore the profile of Mengxuan Shu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qiu L, Song P, Chen P, Wang H, Li F, Shu M, et al.
Front Oncol
. 2024 Sep;
14:1486678.
PMID: 39346738
[This corrects the article DOI: 10.3389/fonc.2021.601185.].
2.
Tao Y, Gong Z, Shen S, Ding Y, Zan R, Zheng B, et al.
iScience
. 2024 May;
27(5):109659.
PMID: 38706841
Abnormal mTORC1 activation by the lysosomal Ragulator complex has been implicated in cancer and glycolytic metabolism associated with drug resistance. Fasting upregulates RNF152 and mediates the metabolic status of cells....
3.
Zan R, Wang H, Shen S, Yang S, Yu H, Zhang X, et al.
Acta Biomater
. 2024 Apr;
180:183-196.
PMID: 38604465
The utilization of biodegradable magnesium (Mg) alloys in the fabrication of temporary non-vascular stents is an innovative trend in biomedical engineering. However, the heterogeneous degradation profiles of these biomaterials, together...
4.
Ma K, Song P, Qing Y, Li Y, Shu M, Yang L, et al.
J Cancer Res Ther
. 2022 Jun;
18(2):391-398.
PMID: 35645105
Objective: This study evaluated the survival outcomes of young (<50 years) and elderly patients (>80 years) with high-risk prostate cancer (PCa) postradical local treatments. Materials And Methods: We identified <50...
5.
Song P, Wang J, Shu M, Di X, Li Y, Qing Y, et al.
Transl Cancer Res
. 2022 Feb;
9(10):6013-6025.
PMID: 35117213
Background: The aim was to evaluate the prognosis of men with all possible high-risk prostate cancers (PCa) stratified by risk factors. Methods: Within the Surveillance, Epidemiology and End Results (SEER)...
6.
Song P, Shu M, Yang L, Di X, Liu P, Liu Z, et al.
Urol Int
. 2021 Sep;
106(1):11-19.
PMID: 34515256
Objective: The aim of this study was to evaluate the survival outcomes of radical prostatectomy (RP), external beam radiotherapy plus brachytherapy (EBRT + BT), and EBRT alone among elderly men...
7.
Song P, Peng Z, Shu M, Wang J, Liu P, Di X, et al.
J Cancer
. 2021 Jul;
12(16):4985-4992.
PMID: 34234867
The aim of this study was to evaluate the prognosis of patients with metastatic prostate cancer (mPCa) in different age groups. Patients with mPCa from 2004 to 2016 in the...
8.
Song P, Shu M, Peng Z, Yang L, Zhou M, Wang Z, et al.
Asian J Surg
. 2021 Apr;
45(1):1-7.
PMID: 33867239
The aim of this study was to evaluate the benefits and safety of transperitoneal and retroperitoneal pyeloplasty for ureteropelvic junction obstruction by a meta-analysis. We searched the databases including PubMed,...
9.
Qiu L, Song P, Chen P, Wang H, Li F, Shu M, et al.
Front Oncol
. 2021 Mar;
11:601185.
PMID: 33747918
Background: Primary pulmonary mucoepidermoid carcinoma (PMEC) is an extremely rare malignancy. Its clinical characteristics and prognosis are not fully understood. This study evaluated clinical characteristics and prognostic factors of PMEC...
10.
Wang Y, Song P, Wang J, Shu M, Wang Q, Li Q
J Cancer
. 2020 Aug;
11(18):5371-5378.
PMID: 32742483
To evaluate the survival difference of radical prostatectomy (RP) and external beam radiotherapy (EBRT) in elderly men (75 years and older) with high-risk (HR) or very high-risk (VHR) prostate cancer...